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Abstract Extensive biomedical applications of nanoparticles are mainly determined by their
safety and compatibility in biological systems. The aim of this study was to compare the
biosafety and biocompatibility of gold nanoparticles (GNPs) prepared with HEPES buffer,
which is popular for cell culture, and sodium citrate, a frequent reducing agent. From
experimental results on the body weight and organ coefficients of acute oral toxicity
tests, it could be observed that HEPES-prepared GNPs are biologically safer than
citric-prepared GNPs at the same dose of 500 μg/kg. The in vitro cell viability was
higher for HEPES-prepared GNPs than citric-prepared GNPs at 5.0- and 10.0-ug/mL
concentrations. More reactive oxygen species (ROS) were generated in the cell
suspension when supplemented with citric-prepared GNPs than HEPES-prepared
GNPs when their concentrations were higher than 20 μg/mL. The results stated that
HEPES-prepared GNPs had better biosafety and biocompatibility than citric-prepared
GNPs. This study not only revealed the influence of reducing agent on biosafety and
biocompatibility of nanomaterials but also provided accumulative evidence for
nanomaterials in biomedical applications.
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Biosafety and biocompatibility are critical factors for almost all biological and medical
applications. In 1997, International Standard ISO-10993 was formulated in order to
provide a comprehensive and general guideline on biocompatibility of materials for
medical applications, with priority on cell culture-based in vitro tests. For modern
biotechnology, biosafety should be guaranteed so that the potential adverse impact
could be minimized and managed in a manner without a negative impact on biodi-
versity and human health. The investigation on the biosafety of nanomaterials could
effectively eliminate doubts from the public. More importantly, quantitative study of
the biocompatibility of nanoparticles is fundamental for us to understand their inter-
actions with biological systems. Therefore, biosafety and biocompatibility of
nanomaterials have attracted more and more attention during the past years [1, 2].
Among a number of nanomaterials, gold nanoparticles (GNPs) have shown tremendous
growth in various biomedical applications because of their convenient preparation, controlla-
ble sizes, and easy modification. Extensive uses of GNPs make it necessary and inevitable to
assess their biosafety and biocompatibility [3]. Previous studies had revealed that gold ions
were toxic on some types of cells, such as red blood cells [4]. In vivo studies revealed that the
toxicity of GNPs was detectable in hematology, blood chemistry, and inflammatory and
pathological response [5–8]. It is necessary to improve the safety of GNPs to avoid harming
the human body.
More evidences have to be accumulated on the toxicity of GNPs for in vivo and in vitro
applications. Previous investigations have revealed that the biosafety of GNPs was likely
dependent on their composition, size, and surface characteristics [9, 10]. Semmler-Behnke
et al. observed that a considerable percentage of GNPs with the size of 18 nm could be
removed from the blood and trapped predominantly in the liver and spleen [11]. GNPs could
be taken up by Kupffer cells in the liver or by macrophages in other places, regardless of the
particle size [12].
In the preparation of GNPs, especially reducing agents could reduce gold ions and
stable GNPs. In the past, sodium citrate has been commonly utilized as the reducing
agent. Under physiological circumstances, however, citrate-prepared GNPs could form
aggregates easily [13, 14]. In a biological system, this condition might be even worse
since high-level accumulation of GNPs in liver and spleen might induce gene muta-
tions and liver necrosis [15]. To date, various approaches on the fabrication of GNPs
have been developed with the aim to improve their biocompatibility and biosafety for
in vivo and in vitro applications [16, 17]. Proteins, peptides, DNA, and other
chemical/biological polymers have been used to prepare GNPs in order to improve
their biocompatibility [18]. Such studies suggested that surface modification could be
essential for safe utilization of GNPs. Therefore, it might be possible to improve the
biocompatibility of nanoparticles by using new reducing reagents [18].
Since many kinds of nanoparticles could interact with cells, it is of importance to ensure
that their modifications do not cause adverse effects. It is desirable to develop biocompatible
and green ways for preparing GNPs. Herein we studied the influence of reducing agents on the
biosafety and biocompatibility of gold nanoparticles; we chose 2-[4-(2-hydroxyethyl)-1-
piperazinyl] ethanesulfonic acid (HEPES), which is a popular buffer extensively applied for
cell culture [19], and a commonly used sodium citrate as reducing agents. Our experimental
results showed that HEPES-prepared GNPs were normally safer in acute toxicity studies under
in vivo and in vitro conditions. It is estimated that our study could potentially extend
applications of GNPs in biomedical areas.
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Materials and Methods
Materials
AuCl3·HCl·4H2O was purchased from Shanghai No. 1 Reagent Factory, China. HEPES was
generously provided by Nanjing SunShine Biotechnology Co., Ltd., China. Dulbecco’s
modified Eagle’s medium (DMEM), fetal bovine serum (FBS), and trypsin-EDTA were
purchased from Gibco, USA. MTT and 2,7-dichlorofluorescein diacetate (DCFH-DA) were
purchased from Beyotime Institute of Biotechnology, China. All other chemical reagents were
of analytical grade. Milli-Q water with electrical resistance of 18.2 MΩ cm was used in all of
our experiments.
Preparation of HEPES-Prepared and Citric-Prepared GNPs
AuCl3·HCl·4H2O and HEPES solutions need to be filtered through 0.22-μm microporous
membrane filters prior to use. HEPES-prepared GNPs were prepared by adding HEPES to
boiling AuCl3·HCl·4H2O aqueous solution with different concentrations corresponding to the
HEPES/Au molar ration of 1:10, 2:10, 4:10, 8:10, and 20:10 and stirred to be homogenous in
order to form a stable mixed liquor.
Citric-prepared GNPs were prepared according to the report of Gu et al. [20]. Briefly, they
were prepared by adding trisodium citrate solution to boiling AuCl3·HCl·4H2O aqueous
solution at the molar ratio of 2:1. The final volume of citric-prepared GNPs was adjusted with
de-ionized water, and the concentration was 100 ppm (0.1 μg/mL of gold).
UV–Vis Measurement
UV–vis measurement was performed with UV2450 UV–vis spectrophotometer (Shimadzu,
Kyoto, Japan) in the absorbance mode and the range from 400 to 650 nm using deionized
water as the reference. The fresh HEPES-prepared and citric-prepared GNP solution without
any further treatment was used as samples for UV–vis measurement using deionized water as a
standard for background correction.
Transmission Electron Microscopy Measurement
TEM measurements were performed in JEM-200 CX microscope (JEOL, Tokyo, Japan)
operated at an accelerating voltage of 80 kV. The samples for TEM measurements were
prepared by placing a drop of GNP solution onto copper grids and drying at room temperature.
Micrographs at various positions were taken, and the sizes of the preferentially present
particles were estimated based on several micrographs. The particle sizes were analyzed by
software Image-pro plus 6.0.
FT-IR Analysis and Zeta Potential Measurement
FT-IR spectra were obtained using Nicolet Avater 370 spectrophotometer (Thermo, MA,
USA). All the colloidal nanoparticles for FT-IR measurement were prepared by evaporating
under reduced pressure to remove the solvent. The resulting precipitate was collected by
centrifuging at 4,000 rpm for 5 min, rinsing periodically with alcohol, and then drying under
vacuum. The samples were then mixed with potassium bromide, ground, and pelletized.
Liquid specimen was prepared by coating a thin film of the pure ionic liquid on a KBr disk.
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The zeta potential of HEPEs-prepared GNPs was measured on a Zetasizer (EEN3690,
Malvern Instruments, Ltd., UK). GNPs were suspended in double-distilled water and placed in
an electrophoretic cell (3mL) and the electrophoreticmobility wasmeasured at room temperature.
Biosafety Studies of In Vivo Applications
Specific pathogen free Spleen-Deficiency (SD) rats of both genders (male, 200-215 g; female,
175-190 g) were obtained from the Experimental Animal Center of Nantong University. For
every cage about three rats were housed under controlled environmental conditions (22±3 °C,
45-70 % relative humidity, and a 12 h light/dark cycle). All animal experiments were approved
by the Care Committee of Nantong University which conducted the ethical review of
the experiments.
The methods of acute toxicity studies were based on the OECD Guidelines for the Testing
of Chemicals, “ROS Results”. The limited dose level of HEPES-prepared and citric-prepared
GNPs at least 500 μg/kg body weight/day (adjusting the final volume with the animal weight
for the given dose) was administered by gavage to six male and six female rats.
The surviving rats were then sacrificed by decapitation under ketamine anesthesia. All
organs were observed macroscopically, and selected vital organs (including liver, spleen and
kidney) were excised, blotted, and weighed. Organ coefficient was also measured. Hematox-
ylin–eosin staining was performed as described [7]. Histological examination was performed
under light microscopy (Olympus CKX 41).
Biocompatibility Studies of In Vitro Applications
Cytotoxicity was evaluated by MTT assay using well-grown passage L929 mouse fibroblasts
under the standard ISO 10993.5-1999. The cells were seeded in 25-cm2 plastic culture flasks
and cultured in DMEM that was supplemented with 10% fetal bovine serum. The mediumwas
renewed every day, and cultures were maintained in a 5-% CO2 incubator at 37 °C. After 80 %
confluence was reached, the cells were detached using 0.25 % trypsin-EDTA and transferred.
L929 mouse fibroblasts were seeded into 96-well plates at a density of 1×104 cells per well.
After 12 h of preculture, the cells were treated with different concentrations of HEPES-
prepared and citric-prepared GNPs (5.0, 10.0, 15.0, 20.0, and 25.0 ppm). Gold-free wells
cultured under the same conditions were used as controls.
After 24 and 48 h of treatment, 20 μLMTT solution (5 mg/mL) was added to each well and
incubated for 4 h in a humidified atmosphere (37 °C, 5 % CO2) to form formazan crystals.
Then, the culture medium was removed, and 150 μL dimethyl sulfoxide was added to each
well to solubilize formazan dye. After 15 min, the absorbance was measured at 490 nm in a
microplate reader.
Measurement of ROS Production
The amount of ROS was utilizing the DCFH-DA assay as previously described [13].
After 24 h of treatment, cells were seeded into 96-well plates at a density of 20,000
cells per well. After recovery, cells were washed twice with Hank's balanced salt
solution and incubated with 50 μM DCFH-DA for 15 min. Cells were then washed
with Hank's balanced salt solution, with non-treated cells used as negative controls
and with rosup-treated cells employed as positive controls. After exposure to the
chemicals, the fluorescence intensity of a total of 5,000 cells was measured by the
FACS Calibur and Cell Quest Pro software (BD Biosciences).
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Statistical Analysis
The results were presented with mean±SD and analyzed using SPSS 13.0. Experimental data
were examined for equal variance and normal distribution prior to statistical analysis. One-way
analysis of variance (ANOVA) was used for statistical analysis. Values were considered
significantly different if P<0.05.
Results
UV–Vis Spectra and TEM Results
Figure 1a illustrates the UV–vis spectra of GNPs prepared with different HEPES/Au ratios.
The absorbance peak at the wavelength of around 525 nm in UV–vis spectra implied
formation of GNPs. With the HEPES/Au ratio varied from 1:10 to 20:10, it could be found
that the peak heights increased gradually. Figure 1b shows TEM images of GNPs
prepared with the HEPES/Au ratio of 2:10, 4:10, and 8:10. There were some HEPES-
prepared GNPs with triangle or polygon forms at the HEPES/Au ratio of 2:10. Sizes
of GNPs were more uniform at the HEPES/Au ratio of 4:10 compared with citric-
prepared GNPs (Fig. 1d). The inset shows the distribution diameter of the GNPs
obtained. Table 1 lists the differences of the corresponding λmax of GNPs prepared
with citrate and HEPES with different HEPES/Au ratios. Such results revealed that
smaller GNPs with narrow and uniform distribution could be obtained at the HEPES/
Au ratio of 4:10. By comparison, citrate-prepared GNPs showed a wider distribution
at the Na3citrate/Au molar ratio of 20:10.
Since uniform GNPs could be obtained at the HEPES/Au ratio of 4:10, the as-prepared
GNPs were then applied for in vitro and in vivo experiments.
FT-IR and Zeta Results
Figure 2a shows the FT-IR spectra of pure HEPES and powders of HEPES-prepared GNPs at
the HEPES/Au ratio of 4:10. It could be found that both HEPES-prepared GNP powders and
pure HEPES exhibited two IR bands at 3,134 and 1,338 cm−1, which could be attributed to the
stretching bands of C–H and C–O, respectively. We can infer that the HEPES formed in the
part of the prepared GNPs. Figure 2a also shows the difference of νS–H vibration band at
2,538 cm−1 between the GNPs and HEPES, which suggests that the S–H bond is broken upon
binding to the gold particle surface to form the bond of S–Au [21]. The function of thiol
groups in HEPES is to prevent Au(0) particles from aggregating and control the growth of
nanoparticle in aqueous media [15].
Since the size of HEPES-prepared GNPs was greater than 10 nm, 50 ppm suspension of
gold nanoparticles was used for the measurement of zeta potential. As can be seen in Fig. 2b,
the gold nanoparticles displayed the highest count with a ζ value of −31.7 mV, indicating a
moderately negative charge on the surface of the nanoparticles.
Biosafety Studies
The study of acute oral toxicity includes mortality, body weight variation, and histological
examination. At a dose of 500 μg/kg, all treated rats grew normally and survived in the
observation period. It could be found from Table 2 that the mean body gain decreased in the
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group fed with citric-prepared GNPs (male, P<0.05; female, P<0.01) after the test. By
comparison, no significant change was observed on the mean body gain for the group fed
with HEPES-prepared GNPs. As shown in Table 3, organ coefficients showed no considerable
change in both sexes except the liver dosed with citric-prepared GNPs (compared with the
control group, male, P<0.05; female, P<0.01). The organ coefficients of liver of both male
Fig. 1 Characterization of HEPES-prepared and citric-prepared GNPs. a UV–vis spectra and photograph of
several vials containing synthesis of HEPES-prepared GNPs by different molar ratios of HEPES/Au: (1) 1:10, (2)
2:10, (3) 4:10, (4) 8:10, (5) 20:10. b TEM images and histograms of size distribution of HEPES-prepared GNPs
(a: 2:10, b 4:10, c 8:10 ) and citric-prepared GNPs (d). The arrows show the triangle or polygon of HEPEs-
prepared GNPs. The sphere GNPs with narrow uniform distribution could be obtained with the HEPES/Au ratio
of 4:10
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and female rats in citric-prepared GNP group were significantly higher than HEPES-prepared
GNP group (P<0.05).
Histological examination of various tissues was carried out for other toxic effects. All of the
specimens harvested during necropsy had no noteworthy reorganization in their histological
structure. Rats exposed to HEPES-prepared and citric-prepared GNPs showed no tissue
damage in any section from kidney and spleen except liver. As shown in Fig. 3, inflammatory
Table 1 UV–vis absorption peak position (λmax) and the average particle diameters (ds) of HEPES-prepared
GNPs changed with different molar ratio of HEPES/Au
Citric-prepared GNPs (citrate/Au) HEPES-prepared GNPs (HEPES/Au)
20:10 2:10 4:10 8:10
λmax (nm) 524.2 527.3 521.4 523.7
ds (nm) 27.42±5.84 32.37±6.59 26.01±4.00a 26.33±5.21
aP<0.01 when compared with citric-prepared GNPs
Fig. 2 a FT-IR spectra of the HEPES-prepared GNPs powder and pure HEPES. b The zeta potential distribution
of R-GNPs in aqueous medium. Both HEPES-prepared GNP powders and pure HEPES exhibited two IR bands
at 3,134 and 1,338 cm−1. The powders of HEPES-prepared GNPs show no detectable characteristic bands of S-H
vibration in the range of 2,500–2,600 cm−1. The gold nanoparticles displayed the highest count with a ζ value of
−31.7 mV, indicating a moderately negative charge on the surface of the nanoparticles
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liver injury could be observed in the group treated with citric-prepared treated GNPs but not
with HEPES-prepared GNPs.
Biocompatibility Studies
Figure 4a illustrated the MTT reduction reaction of L929 cells cultured for 24 and 48 h in the
medium supplemented with HEPES-prepared or citric-prepared GNPs at different concentra-
tions, respectively. The lines mean the OD of control groups at 24 and 48 h. The L929
fibroblasts co-cultured with 5.0 and 10.0 ppm HEPES-prepared GNPs presented a high
proliferation rate compared to the control group throughout the culture time (24 h, P<0.05;
48 h, P<0.01). Furthermore, cell viability was higher for 5.0 and 10.0 ppm HEPES-prepared
GNPs than citric-prepared GNPs (P<0.05). As GNP concentration increased, L929 cell
proliferation was inhibited in varying degrees. Higher doses (20.0 and 25.0 ppm) of citric-
Table 2 Body weight of rats in HEPES-prepared and citric-prepared GNPs acute oral toxicity study at a limited
















206.48±4.97 206.54±4.78 205.84±4.32 181.40±4.53 181.02±4.87 182.38±4.43
Final body
weight (g)
260.38±10.07 245.14±10.59a, c 258.87±9.46 229.60±7.71 214.24±10.43a, c 229.44±9.89
Body weight
gain (g)
53.90±7.51 38.60±5.81a, c 53.04±6.28 48.20±6.14 33.22±5.57b, d 47.06±12.64
Values were means±SD of six mice in each group
aP<0.05 when compared with the control group in the same sex rats
bP<0.01when compared with the control group in the same sex rats
cP<0.05when citric-prepared GNPs compared to the same concentrations of HEPES-prepared GNPs group
dP<0.01 when citric-prepared GNPs compared to the same concentrations of HEPES-prepared GNPs group














Liver (g/100 g bw) 3.46±0.28 3.86±0.23a, c 3.48±0.29 2.78±0.26 3.42±0.27b, c 2.98±0.25
Kidneys (g/100 g bw) 0.94±0.12 0.93±0.08 0.90±0.07 0.74±0.10 0.82±0.09 0.81±0.10
Heart (g/100 g bw) 0.41±0.02 0.43±0.04 0.40±0.01 0.35±0.02 0.36±0.02 0.34±0.01
Spleen (g/100 g bw) 0.27±0.05 0.26±0.05 0.25±0.06 0.25±0.03 0.28±0.03 0.24±0.05
Values were means±SD of six mice in each group
a Significantly different with the control group in the same sex at P<0.05
b Very significantly different from control group, P<0.01
c Significantly different with HEPES-prepared GNPs group in the same sex at P<0.05
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prepared GNPs (48 h) showed a thorough inhibition on cell proliferation. Cell viability at 48 h
was significantly higher with 20.0 and 25.0 ppm HEPES-prepared GNPs than those with
citric-prepared GNPs (P<0.01), although the HEPES GNPs also inhibit cell proliferation at 20
and 25 ppm at 48 h.
One noticeable effect on biocompatibility was different cell shapes and morphology in the
monolayer. It could be found from Fig. 4b that the shapes of cells treated with 20.0 ppm
HEPES-prepared GNPs were triangle, spindle, and extended pseudopodia to adhere to the
culture flasks. By comparison, only a few cells treated with 20.0 ppm citric-prepared GNPs
could survive and maintain the triangle and spindle shape.
Fig. 3 Histological analysis of various organs after 500 μg/kg body weight citric-prepared and HEPES-prepared
GNP treatment. Slight inflammation was observed in pathological sections of liver tissue in the citric-prepared
GNP group (H&E, ×200)
Fig. 4 The cytotoxicity test of GNPs was performed using mouse fibroblast cells, which were treated with
different concentrations of HEPES-prepared and citric-prepared GNPs (0 (as the control), 5.0, 10.0, 15.0, 20.0,
and 25.0 ppm). After 24 and 48 h, the cells’ vitality was tested by MTT assay. The absorbance was measured at
the wavelength of 490 nm in a microplate reader. The growth curve of MTT reduction reaction results (a), the cell
proliferation and morphology of 20.0 ppm HEPES-prepared GNPs group (b) and 20.0 ppm citric-prepared GNPs
(c) at 48 h. Asterisk significantly different from control group, P<0.05; double asterisks very significantly
different from control group, P<0.01. Number sign significantly different compared to the same concentrations
of GNP group, P<0.05; number sign pair very significantly different from the same concentrations of GNP
group, P<0.01
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ROS Results
In the following, we examined the dependence of ROS production of cells on treatment of
HEPES-prepared and citric-prepared GNPs (Fig. 5). It could be found that the amount of ROS
with HEPES-prepared and citric-prepared GNPs at the concentration of 5.0 and 10.0 ppm were
similar to the negative group. With the increase of GNP concentration to 15.0 ppm, there were
more ROS generated in the cells treated with citric-prepared GNPs than with HEPES-prepared
GNPs (P<0.01). Although the amounts of ROS increased with the increase of GNP concen-
tration, they were significantly lower than the positive control (Fig. 5, inset). Overall, there
were more ROS generated in citric-prepared GNPs than in HEPES-prepared GNPs.
Discussion
In this study, we prepared GNPs with HEPES, which is a popular buffer solution extensively
used in biological laboratories for cell and tissue culture [16]. HEPES has a pKa close to
physiological conditions (pH=7.5), maximum aqueous solubility, low permeability to cell
membrane, and high chemical stability [17]. It has been reported that a simple one-pot
synthesis of three-dimensional gold nanocrystals with multi-tips could be fabricated by adding
HAuCl4 solution into HEPES without shaking and heating [17], and HEPES is serving as both
reducing and shape-directing agent. GNPs with polygon forms could also be prepared by
mixing HEPES with an aqueous solution of 6 ppm Au (III) at room temperature [16]. Herein
we mixed HEPES to boiling AuCl3·HCl·4H2O aqueous solution and optimized the conditions
in order to obtain sphere GNPs to improve their biosafety and biocompatibility [18]. Our
results showed that GNPs with sphere shape, uniform distribution, and well stability could be
Fig. 5 Amount of ROS produced relative to L929 cells treated with different concentrations of HEPES-prepared
and citric-prepared GNPs (5.0, 10.0, 15.0, 20.0, and 25.0 ppm). The insets show relative ROS produced in cells
following positive and negative controls. Data represent mean±SD (n=5). Double asterisks very statistically
significantly different between the citric-prepared GNP treated group and HEPES-prepared GNP treated group,
P<0.01
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achieved at the HEPES/Au ratio of 4:10, which indicated that the number of thiol groups in
ionic liquid plays an important role in the stabilization of gold nanoparticles. The interaction
between gold atoms and thiol groups in HEPES could be further investigated by FT-IR spectra.
It is believed that the mechanism of GNPs formation in our approach was similar to that in
previous reports [16]. The surface of GNPs could be modified by the thiol group in HEPES
because of the strong connection between the gold surface and thiol/amine [19]. FT-IR results
confirmed this step with the stretching band of methylene, which could be ascribed to the
modification of the thiol group on the surface of gold clusters [20]. We think that the boiling
process could facilitate the stabilization of GNPs and prevent the aggregation at higher
temperature. The process of GNP formation was further proved by the characteristic bands
in surface plasmon resonance (SPR) [22]. The moderate value of zeta potential might also
reflect that the S–H bond is broken upon binding to the gold particle surface to form the bond
of S–Au and the electrostatically stable form of HEPES-prepared GNPs.
The harmfulness of GNPs to mammalian cells was thought to depend on their sizes or
residual hazardous chemicals. Pan et al. reported that GNPs of 1–2 nm in size were more toxic
than 15-nm gold colloids in the study of the cytotoxicity of TPPMS/TPPTS-modified gold
nanoparticles [23]. Their results suggested that the sizes of GNPs might play dominant roles in
the metabolism of nanoparticles [9]. Shukla et al. found that Au (0) nanoparticles were not
cytotoxic and might become a suitable candidate for nanomedicine. The reason is that GNPs
could reduce the production of reactive oxygen and nitrite species without eliciting secretion of
proinflammatory cytokines TNF-α and IL1-β [24].
We demonstrated that HEPES-prepared GNPs with a size of 26.01 nm exhibited improved
biosafety compared with citric-prepared GNPs. For example, HEPES-prepared GNPs could
not pass through the glomerular filtration of kidneys due to its size and negative electrostatic
potential [25]. The bioaccumulation of HEPES-prepared GNPs may be because of their
regulation in the reticulo-endothelial system, which is involved in the uptake and metabolism
of exogenous nanoparticles in these tissues [26]. Interestingly, there were more viable cells in
the groups treated with 5.0 and 10.0 ppm HEPES-prepared GNPs (48 h) than in the control,
which was consistent with our previous study: a concentration of 5.0 ppm gold nanoparticle
has the best effect on the promotion of cell growth [27]. This may be due to the fact that the
small amount of gold nanoparticles could enter the cell and enhance DNA synthesis. Our
in vitro results confirmed that HEPES-prepared GNPs showed better biocompatibility at the
concentration of 5.0 to 10.0 ppm. Although GNPs have been considered bioinert and
therapeutically used, GNPs might change the hematology and blood chemistry, indicating
potential damage on liver and kidney as well as histological disorders, such as apoptosis and
inflammation in various organs [6, 7, 28]. While administrated to rats, citric-prepared GNPs
could disappear from the circulation and localized in the tissues, primarily the liver [26]. Our
results indicate that the administration of HEPES-prepared GNPs could not induce extensive
inflammation on rats, which are superior to citric-prepared GNPs. In liver (heavy metal
detoxification organ), there were some inflammatory cells after injection of citric-prepared
GNPs. It is probably caused by the reducing agent citric acid. Such experimental results agreed
with the previous report from Lasagna-Reeves et al. [3].
The MTT and ROS assay were utilized to characterize the effect of HEPES-prepared and
citric-prepared GNPs on L929 cell proliferation. Oxidative stress, which includes ROS
generation, is currently the most popular theory in the study of nanoparticle toxicity [29].
Oxidative stress has been shown to occur in cells following exposure to gold nanoparticles
[30]. Citric-prepared GNP was more effective in increasing ROS compared to the negative
control as the concentration rises above 20.0 ppm, which was consistent with the fact that the
proliferation of cells was significantly inhibited by citric-prepared GNPs at 20.0- and 25.0-ppm
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concentrations. Some cells began to shrink and disintegrate, which might be due to the
increased ROS levels.
Interestingly, it was found that ROS production slightly decreased in groups treated with
HEPES-prepared GNPs at the low concentrations. It might be possible that agents binding to
the AuNPs through Au–S bonds could decrease the catalytic activity of the AuNPs. Pan et al.
demonstrated that several thiol-containing antioxidants could significantly reduce their toxic
effects [29]. MTT and ROS results showed that cytotoxicity might depend on both the
concentration of GNPs and the type of reducing agent used.
Conclusions
In summary, our investigation demonstrated that HEPES could get a better reducing agent and
stabilizer for GNPs from the view of “biocompatible”. HEPES-prepared GNPs showed better
biosafety and biocompatibility than citric-prepared GNPs under both in vivo and in vitro
circumstances. Preparation of GNPs with HEPES is convenient for biomedical applications.
This study not only demonstrated the key fact of reducing agent but also accumulated more
evidence for the study of biosafety and biocompatibility of nanoparticles.
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